Stock Markets February 9, 2026

Goldman Sees U.S. IPO Proceeds Jump to $160 Billion in 2026 as Deal Flow Recovers

Bank forecasts fourfold increase in proceeds and a doubling of listings as large private companies near public markets

By Maya Rios
Goldman Sees U.S. IPO Proceeds Jump to $160 Billion in 2026 as Deal Flow Recovers

Goldman Sachs analysts project a sharp recovery in U.S. initial public offerings in 2026, forecasting proceeds of $160 billion and roughly 120 listings as improving economic growth, firmer equity prices and easier financial conditions revive dealmaking. A small group of highly valued private companies - including SpaceX, OpenAI and Anthropic - are expected to determine the scale of the year’s fundraising, while software and healthcare firms will account for most of the listings by number.

Key Points

  • Goldman Sachs forecasts U.S. IPO proceeds of $160 billion in 2026, a fourfold increase from the recent pace, and expects roughly 120 listings.
  • Twelve firms have raised about $5 billion via IPOs so far in 2026; notable pipeline names include Forgent Power, Eikon Therapeutics and Cerebras Systems.
  • Software and healthcare are projected to lead by volume, while a small number of late-stage tech and AI companies - including SpaceX, OpenAI and Anthropic - could drive total proceeds.

Goldman Sachs analysts are forecasting a substantial rebound in U.S. equity offerings in 2026, projecting that IPO proceeds will rise to a record $160 billion - roughly four times the prior pace - as the market’s dealmaking momentum returns. The bank also expects the number of initial public offerings to climb to about 120 listings nationwide, driven by what it describes as improving economic growth, stronger equity prices and easier financial conditions that are restoring corporate appetite for public markets.

According to the note published by the analysts, the $160 billion prediction represents the largest annual total in absolute dollar terms on record. They caution, however, that even at that scale IPO proceeds would still constitute only a modest share of total U.S. market capitalization, given how much the equity market has expanded over the past decade.

So far in 2026, 12 companies have completed IPOs raising about $5 billion in aggregate. The group includes AI equipment maker Forgent Power and biopharmaceutical firm Eikon Therapeutics. Among private candidates that could add substantial proceeds to the calendar is AI chipmaker Cerebras Systems - a rival to Nvidia - which recently secured $1 billion in a late-stage financing that valued the company at $23 billion and remains a contender for a public listing.

Goldman notes that software and healthcare companies are expected to dominate the pipeline in terms of volume of listings, while a relatively small number of late-stage technology and artificial intelligence companies are likely to account for the bulk of total proceeds. At the center of investor attention are ultra-valuable private firms such as SpaceX, Anthropic and OpenAI, whose potential public debuts the analysts say will help determine both the size and tone of the coming IPO cycle.

The bank modeled a range of outcomes for listings by large private companies in 2026, with total proceeds spanning roughly $80 billion at the low end to almost $200 billion at the high end, compared with the $160 billion base case.

Analysts also flagged risks to the outlook. An early-year selloff in software stocks has underlined valuation risk for the sector, which accounts for about a quarter of the IPO backlog. The analysts emphasized that continued volatility in share prices and corporate confidence represent key macro risks to the forecast. They specifically called out the heavy weight of software in the backlog as an additional vulnerability.

In sum, Goldman’s projections reflect a market dynamic in which broad-based improvements in financial conditions and a few very large private listings could combine to produce a record year for IPO proceeds. At the same time, sector-specific valuation pressures and the prospect of renewed market volatility could temper activity or alter the ultimate fundraising totals.

Risks

  • Volatility in share prices and falling corporate confidence could derail dealmaking and reduce IPO activity - this mainly affects equity markets and technology sector listings.
  • A heavy concentration of software companies in the IPO backlog exposes the pipeline to sector-specific valuation corrections that could lower proceeds or postpone listings - impacting software and related tech firms.

More from Stock Markets

Asian Markets Muted as U.S. Tariff Moves Keep Investors Cautious Feb 22, 2026 Regis Healthcare Shares Jump After Solid First-Half Results Feb 22, 2026 Samsung Shares Surge to Record on Report It Could Be Nvidia's Exclusive HBM4 Supplier Feb 22, 2026 Microsoft gaming leadership reshuffled as Phil Spencer retires and Asha Sharma named CEO Feb 22, 2026 U.S. Futures Slide as Trump Moves to Reapply Tariffs Under Alternate Law; Nvidia Results in Focus Feb 22, 2026